000 01741 a2200457 4500
005 20250517085904.0
264 0 _c20170217
008 201702s 0 0 eng d
022 _a1432-1041
024 7 _a10.1007/s00228-016-2050-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKullak-Ublick, Gerd A
245 0 0 _aNo major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cJul 2016
300 _a797-805 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aATP Binding Cassette Transporter, Subfamily B, Member 1
_xgenetics
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aDuodenum
_xdrug effects
650 0 4 _aFemale
650 0 4 _aFolic Acid
_xblood
650 0 4 _aHealthy Volunteers
650 0 4 _aHumans
650 0 4 _aIntestinal Absorption
_xdrug effects
650 0 4 _aMale
650 0 4 _aMultidrug Resistance-Associated Proteins
_xgenetics
650 0 4 _aOrganic Anion Transporters
_xgenetics
650 0 4 _aProton-Coupled Folate Transporter
_xgenetics
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aTerfenadine
_xanalogs & derivatives
650 0 4 _aVitamin D
_xanalogs & derivatives
650 0 4 _aYoung Adult
700 1 _aGubler, Christoph
700 1 _aSpanaus, Katharina
700 1 _aIsmair, Manfred G
700 1 _aClaro da Silva, Tatiana
700 1 _aJetter, Alexander
773 0 _tEuropean journal of clinical pharmacology
_gvol. 72
_gno. 7
_gp. 797-805
856 4 0 _uhttps://doi.org/10.1007/s00228-016-2050-0
_zAvailable from publisher's website
999 _c25872403
_d25872403